NO950211L - Vaksiner mot metazo-parasitter - Google Patents

Vaksiner mot metazo-parasitter

Info

Publication number
NO950211L
NO950211L NO950211A NO950211A NO950211L NO 950211 L NO950211 L NO 950211L NO 950211 A NO950211 A NO 950211A NO 950211 A NO950211 A NO 950211A NO 950211 L NO950211 L NO 950211L
Authority
NO
Norway
Prior art keywords
metazo
parasites
antigen
protective
antigens
Prior art date
Application number
NO950211A
Other languages
English (en)
Other versions
NO950211D0 (no
Inventor
William David Smith
Stuart Kevin Smith
Jacqueline Murray
Susan Liddell
David Patrick Knox
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215505A external-priority patent/GB9215505D0/en
Priority claimed from GB929217635A external-priority patent/GB9217635D0/en
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Publication of NO950211L publication Critical patent/NO950211L/no
Publication of NO950211D0 publication Critical patent/NO950211D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer nye metazo-parasittantigener, nukleinsyrer som koder disse, og deres anvendelse ved kontroll av sykdom forårsaket av helmint- og andre metazo-parasitter, særlig helmint- og artropod-parasitter i husdyr. Spesielt tilveiebringer oppfinnelsen et beskyttende metazo-parasittantigen eller antigenfragmenter, komponenter eller prekursorer derav og funksjonelt likeverdige derivater, analoger eller varianter derav, som har beskyttende antigen aktivitet mot én eller flere metazo-parasitter, idet antigenet erå kunne bindes til pepstatin og som i nativ form er et integrert membranprotein eller proteinkompleks. Det tilveiebringes også antigener som karakteriseres ved å ha aspartyl-proteinase-lignende og/eller nøytral endopeptidase-lignende aktivitet.
NO950211A 1992-07-21 1995-01-20 Vaksiner mot metazo-parasitter NO950211D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929215505A GB9215505D0 (en) 1992-07-21 1992-07-21 Vaccines
GB929217635A GB9217635D0 (en) 1992-08-19 1992-08-19 Vaccines
PCT/GB1993/001521 WO1994002169A1 (en) 1992-07-21 1993-07-20 Vaccines against metazoan parasites

Publications (2)

Publication Number Publication Date
NO950211L true NO950211L (no) 1995-01-20
NO950211D0 NO950211D0 (no) 1995-01-20

Family

ID=26301293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950211A NO950211D0 (no) 1992-07-21 1995-01-20 Vaksiner mot metazo-parasitter

Country Status (20)

Country Link
EP (1) EP0652769B1 (no)
JP (1) JPH07509698A (no)
KR (1) KR950702435A (no)
CN (1) CN1088217A (no)
AT (1) ATE134878T1 (no)
AU (1) AU675443B2 (no)
CA (1) CA2140673A1 (no)
CZ (1) CZ14495A3 (no)
DE (1) DE69301733T2 (no)
ES (1) ES2085163T3 (no)
FI (1) FI950248L (no)
HU (1) HUT70985A (no)
IL (1) IL106407A (no)
MY (1) MY131433A (no)
NO (1) NO950211D0 (no)
NZ (1) NZ254210A (no)
PL (1) PL307170A1 (no)
TR (1) TR27329A (no)
WO (1) WO1994002169A1 (no)
ZW (1) ZW8893A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9303681D0 (en) * 1993-02-24 1993-04-14 Pitman Moore Inc Vaccines
GB9322702D0 (en) * 1993-11-03 1993-12-22 Agricultural & Food Res Vaccines
CA2182178A1 (en) * 1994-03-25 1995-10-05 David Patrick Knox Vaccines against helminthic parasites
GB9406708D0 (en) * 1994-04-05 1994-05-25 Mallinckrodt Veterinary Inc Vaccines
AU4624997A (en) * 1996-10-10 1998-05-05 Bayer Aktiengesellschaft Nematode proteins, dna sequences coding therefor, their specific antibodies and their use in identifying nematicidal active substances
KR100900837B1 (ko) 2007-12-07 2009-06-04 (주)두비엘 리포펩타이드와 폴리(ｉ:ｃ)를 아쥬반트로 포함하는 강력한백신 조성물
ES2441880B1 (es) * 2012-07-06 2014-11-13 Universidad De Granada Composición basada en polipéptidos para el tratamiento de miasis
CN103014173B (zh) * 2013-01-17 2014-04-16 福建出入境检验检疫局检验检疫技术中心 一种pcr检测鉴定盖罩大蜗牛的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8619293D0 (en) * 1986-08-07 1986-09-17 Munn E A Anthelmintic agents
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
US5525508A (en) * 1991-02-06 1996-06-11 Biotech Australia Pty Limited Haemonchus contortus vaccine

Also Published As

Publication number Publication date
JPH07509698A (ja) 1995-10-26
TR27329A (tr) 1995-01-12
MY131433A (en) 2007-08-30
KR950702435A (ko) 1995-07-29
CZ14495A3 (en) 1995-09-13
ATE134878T1 (de) 1996-03-15
IL106407A0 (en) 1993-11-15
PL307170A1 (en) 1995-05-15
IL106407A (en) 1997-09-30
AU4579993A (en) 1994-02-14
NZ254210A (en) 1996-11-26
ZW8893A1 (en) 1994-06-01
FI950248A0 (fi) 1995-01-20
ES2085163T3 (es) 1996-05-16
FI950248A7 (fi) 1995-01-20
AU675443B2 (en) 1997-02-06
CA2140673A1 (en) 1994-02-03
CN1088217A (zh) 1994-06-22
EP0652769A1 (en) 1995-05-17
DE69301733T2 (de) 1996-10-31
FI950248L (fi) 1995-01-20
NO950211D0 (no) 1995-01-20
DE69301733D1 (de) 1996-04-11
HUT70985A (en) 1995-11-28
WO1994002169A1 (en) 1994-02-03
EP0652769B1 (en) 1996-03-06
HU9500185D0 (en) 1995-03-28

Similar Documents

Publication Publication Date Title
BR0113112A (pt) Anticorpos, de integrina antidual, composições, métodos e usos
CY1119650T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
ATE390933T1 (de) Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
DE69940545D1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
NO913558D0 (no) Fremgangsmaate ved fremstilling av xenogene antistoffer.
BR0113110A (pt) Anticorpos anti-tnf, composições, métodos e usos
BR0014282A (pt) Vacinas
DE69127440D1 (de) Lebende vakzine
NO20063026L (no) Antistoffer
EP0855918A4 (en) INTERLEUKIN-15 FROM CHICKENS AND ITS USE
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
NO950211L (no) Vaksiner mot metazo-parasitter
DK0831900T3 (da) Fremgangsmåder til at rejse antistoffer imod E. Coli i CS4-CFA/1 familien
Pruett et al. Antigenicity and immunogenicity of Hypoderma lineatum soluble proteins in the bovine host
Seed Trypanosoma gambiense and T. equiperdum: Characterization of variant specific antigens
ATE111606T1 (de) Ein gattungsspezifisches listeria-antigen, identifiziert durch monoklonale antikörper.
DE68928933D1 (de) Faser-hemagglutinin von b. pertussis
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
WO2002060390A3 (en) Induction of immune responses to isoaspartyl-modified antigens
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
SE9900674L (sv) Kvalsterprotein
TH14161A (th) วัคซีน
BR9711809A (pt) Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application